HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

YM-201627

an orally active antitumor agent with selective inhibition of vascular endothelial cell proliferation; structure in first source

Also Known As:

N,N-diethyl-2-(3-imidazo(2,1-b)(1,3)(benzothiazol-2-yl)phenoxy)ethanamine

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - YM-201627: 1

Experts

1.	Amino, Nobuaki: 1 article (07/2006)
2.	Ideyama, Yukitaka: 1 article (07/2006)
3.	Kudoh, Masafumi: 1 article (07/2006)
4.	Kuromitsu, Sadao: 1 article (07/2006)
5.	Matsuhisa, Akira: 1 article (07/2006)
6.	Samizu, Kiyohiro: 1 article (07/2006)
7.	Shibasaki, Masayuki: 1 article (07/2006)
8.	Tajinda, Katsunori: 1 article (07/2006)
9.	Yamano, Mayumi: 1 article (07/2006)

Related Diseases

1.	Neoplasms (Cancer) 07/08/2006 - "These results suggest that YM-201627 is a selective growth inhibitor of endothelial cells, which may be useful for treatment of solid tumors."

Related Drugs and Biologics

1.	Growth Inhibitors